Literature DB >> 1104162

Combination of radiotherapy and surgery in the treatment of head and neck cancers.

Y Cachin, F Eschwege.   

Abstract

Entities:  

Mesh：

Year:  1975        PMID： 1104162     DOI： 10.1016/s0305-7372(75)80002-8

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  9 in total

1.  [Complications after surgery of ENT-tumors. A comparison between preoperatively irradiated and nonirradiated patients].

Authors:  K Laniado; K Schumann; T Silber
Journal:  Arch Otorhinolaryngol       Date:  1980

Review 2.  Chemotherapeutic management of head and neck cancer.

Authors:  M Al-Sarraf
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.

Authors:  David I Rosenthal; Abdallah S R Mohamed; Adam S Garden; William H Morrison; Adel K El-Naggar; Mona Kamal; Randal S Weber; Clifton D Fuller; Lester J Peters
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-07-10       Impact factor: 7.038

Review 4.  Clinical trials with fluorinated pyrimidines in patients with head and neck cancer.

Authors:  M al-Sarraf
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

5.  Treatment results for hypopharyngeal cancer by different treatment strategies and its secondary primary--an experience in Taiwan.

Authors:  Morgan Fu-Ti Chang; Hung-Ming Wang; Chung-Jan Kang; Shiang-Fu Huang; Chien-Yu Lin; Kang-Hsing Fang; Eric Yen-Chao Chen; I-How Chen; Chun-Ta Liao; Joseph Tung-Chieh Chang
Journal:  Radiat Oncol       Date:  2010-10-07       Impact factor: 3.481

6.  A phase I clinical trial of prolonged infusion of hydroxyurea in combination with hyperfractionated, accelerated, external radiation therapy in patients with advanced squamous cell cancer of the head and neck.

Authors:  J J Beitler; R V Smith; H Haynes; C E Silver; A Quish; T Kotz; M Serrano; A Brook; S Wadler
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850

7.  Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formation.

Authors:  G Los; f A Blommaert; R Barton; D D Heath; L den Engelse; C Hanchett; D Vicario; R Weisman; K T Robbins; S B Howell
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis.

Authors:  F Janot; J Klijanienko; A Russo; J P Mamet; F de Braud; A K El-Naggar; J P Pignon; B Luboinski; E Cvitkovic
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

9.  Survival outcomes of patients with advanced oral cavity squamous cell carcinoma treated with multimodal therapy: a multi-institutional analysis.

Authors:  Han Zhang; Peter T Dziegielewski; Vince L Biron; Jacek Szudek; Khaled H Al-Qahatani; Daniel A O'Connell; Jeffrey R Harris; Hadi Seikaly
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-04-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.